The DOI matches its Crossref record; 234 of the 234 references it cites were found in a registry or an index.
Cellular and molecular mechanisms of intestinal fibrosis
Open accessAbstract
Fibrosis is a chronic and progressive process characterized by an excessive accumulation of extracellular matrix (ECM) leading to stiffening and/or scarring of the involved tissue. Intestinal fibrosis may develop in several different enteropathies, including inflammatory bowel disease. It develops through complex cell, extracellular matrix, cytokine and growth factor interactions. Distinct cell types are involved in intestinal fibrosis, such as resident mesenchymal cells (fibroblasts, myofibroblasts and smooth muscle cells) but also ECM-producing cells derived from epithelial and endothelial cells (through a process termed epithelial- and endothelial-mesenchymal transition), stellate cells, pericytes, local or bone marrow-derived stem cells. The most important soluble factors that regulate the activation of these cells include cytokines, chemokines, growth factors, components of the renin-angiotensin system, angiogenic factors, peroxisome proliferator-activated receptors, mammalian target of rapamycin, and products of oxidative stress. It soon becomes clear that although inflammation is responsible for triggering the onset of the fibrotic process, it only plays a minor role in the progression of this condition, as fibrosis may advance in a self-perpetuating fashion. Definition of the cellular and molecular mechanisms involved in intestinal fibrosis may provide the key to developing new therapeutic approaches.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Cellular and molecular mechanisms of fibrosis
Wynn, T. (2008) · The Journal of Pathology · doi:10.1002/path.2277 · Cited by 4,495
Nagase, H., & Woessner, J. F. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.31.21491 · Cited by 3,912
Genome-wide association defines more than 30 distinct susceptibility loci for Crohn's disease
the NIDDK IBD Genetics Consortium, Barrett, J. C., the Belgian-French IBD Consortium, the Wellcome Trust Case Control Consortium, Hansoul, S., Nicolae, D. L., Cho, J. H., Duerr, R. H., Rioux, J. D., Brant, S. R., et al. (2008) · Nature Genetics · doi:10.1038/ng.175 · Cited by 2,593
Role of platelet-derived growth factors in physiology and medicine
Andrae, J., Gallini, R., & Betsholtz, C. (2008) · Genes & Development · doi:10.1101/gad.1653708 · Cited by 2,438
The epithelial–mesenchymal transition: new insights in signaling, development, and disease
Lee, J. M., Dedhar, S., Kalluri, R., & Thompson, E. W. (2006) · The Journal of Cell Biology · doi:10.1083/jcb.200601018 · Cited by 2,019
TLR4 enhances TGF-β signaling and hepatic fibrosis
Seki, E., De Minicis, S., Österreicher, C. H., Kluwe, J., Osawa, Y., Brenner, D. A., & Schwabe, R. F. (2007) · Nature Medicine · doi:10.1038/nm1663 · Cited by 1,942
Angiotensin II cell signaling: physiological and pathological effects in the cardiovascular system
Mehta, P. K., & Griendling, K. K. (2007) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00287.2006 · Cited by 1,924
Nod2-Dependent Regulation of Innate and Adaptive Immunity in the Intestinal Tract
Kobayashi, K. S., Chamaillard, M., Ogura, Y., Henegariu, O., Inohara, N., Nuñez, G., & Flavell, R. A. (2005) · Science · doi:10.1126/science.1104911 · Cited by 1,776
The immunological and genetic basis of inflammatory bowel disease
Bouma, G., & Strober, W. (2003) · Nature Reviews Immunology · doi:10.1038/nri1132 · Cited by 1,767
Fibrotic disease and the TH1/TH2 paradigm
Wynn, T. A. (2004) · Nature Reviews Immunology · doi:10.1038/nri1412 · Cited by 1,765
Physiology of Local Renin-Angiotensin Systems
Paul, M., Poyan Mehr, A., & Kreutz, R. (2006) · Physiological Reviews · doi:10.1152/physrev.00036.2005 · Cited by 1,739
The myofibroblast in wound healing and fibrocontractive diseases
Gabbiani, G. (2003) · The Journal of Pathology · doi:10.1002/path.1427 · Cited by 1,630
Plasticity of CD4+ T Cell Lineage Differentiation
Zhou, L., Chong, M. M. W., & Littman, D. R. (2009) · Immunity · doi:10.1016/j.immuni.2009.05.001 · Cited by 1,551
Negative regulation of Toll-like receptor-mediated immune responses
Liew, F. Y., Xu, D., Brint, E. K., & O'Neill, L. A. J. (2005) · Nature Reviews Immunology · doi:10.1038/nri1630 · Cited by 1,509
Dignass, A., Van Assche, G., Lindsay, J. O., Lémann, M., Söderholm, J., Colombel, J. F., Danese, S., D'Hoore, A., Gassull, M., Gomollón, F., et al. (2010) · Journal of Crohn's and Colitis · doi:10.1016/j.crohns.2009.12.002 · Cited by 1,498
Common and unique mechanisms regulate fibrosis in various fibroproliferative diseases
Wynn, T. A. (2007) · Journal of Clinical Investigation · doi:10.1172/jci31487 · Cited by 1,456
Cario, E., & Podolsky, D. K. (2000) · Infection and Immunity · doi:10.1128/iai.68.12.7010-7017.2000 · Cited by 1,246
Chung, J., Kuo, C. J., Crabtree, G. R., & Blenis, J. (1992) · Cell · doi:10.1016/0092-8674(92)90643-q · Cited by 1,150
Faubion, W. A., Loftus, E. V., Harmsen, W. S., Zinsmeister, A. R., & Sandborn, W. J. (2001) · Gastroenterology · doi:10.1053/gast.2001.26279 · Cited by 1,144
Interactions between extracellular matrix and growth factors in wound healing
Schultz, G. S., & Wysocki, A. (2009) · Wound Repair and Regeneration · doi:10.1111/j.1524-475x.2009.00466.x · Cited by 1,126
Endothelial-pericyte interactions in angiogenesis
Gerhardt, H., & Betsholtz, C. (2003) · Cell and Tissue Research · doi:10.1007/s00441-003-0745-x · Cited by 1,057
IL-22 ameliorates intestinal inflammation in a mouse model of ulcerative colitis
Sugimoto, K., Ogawa, A., Mizoguchi, E., Shimomura, Y., Andoh, A., Bhan, A. K., Blumberg, R. S., Xavier, R. J., & Mizoguchi, A. (2008) · Journal of Clinical Investigation · doi:10.1172/jci33194 · Cited by 1,023
Myofibroblasts. I. Paracrine cells important in health and disease
Powell, D. W., Mifflin, R. C., Valentich, J. D., Crowe, S. E., Saada, J. I., & West, A. B. (1999) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.1999.277.1.c1 · Cited by 924
Perspective Article: Tissue repair, contraction, and the myofibroblast
Desmoulière, A., Chaponnier, C., & Gabbiani, G. (2005) · Wound Repair and Regeneration · doi:10.1111/j.1067-1927.2005.130102.x · Cited by 892
Fichtner-Feigl, S., Strober, W., Kawakami, K., Puri, R. K., & Kitani, A. (2006) · Nature Medicine · doi:10.1038/nm1332 · Cited by 889
Activin-Binding Protein from Rat Ovary Is Follistatin
Nakamura, T., Takio, K., Eto, Y., Shibai, H., Titani, K., & Sugino, H. (1990) · Science · doi:10.1126/science.2106159 · Cited by 883
NOD2 is a negative regulator of Toll-like receptor 2–mediated T helper type 1 responses
Watanabe, T., Kitani, A., Murray, P. J., & Strober, W. (2004) · Nature Immunology · doi:10.1038/ni1092 · Cited by 840
Wehkamp, J., Harder, J., Weichenthal, M., Schwab, M., Schäffeler, E., Schlee, M., Herrlinger, K. R., Stallmach, A., Noack, F., Fritz, P., et al. (2004) · Gut · doi:10.1136/gut.2003.032805 · Cited by 823
Innate and Adaptive Interleukin-22 Protects Mice from Inflammatory Bowel Disease
Zenewicz, L. A., Yancopoulos, G. D., Valenzuela, D. M., Murphy, A. J., Stevens, S., & Flavell, R. A. (2008) · Immunity · doi:10.1016/j.immuni.2008.11.003 · Cited by 800
Lu, L.-F., Thai, T.-H., Calado, D. P., Chaudhry, A., Kubo, M., Tanaka, K., Loeb, G. B., Lee, H., Yoshimura, A., Rajewsky, K., et al. (2009) · Immunity · doi:10.1016/j.immuni.2008.11.010 · Cited by 783
The mTOR pathway in the control of protein synthesis
Wang, X., & Proud, C. G. (2006) · Physiology · doi:10.1152/physiol.00024.2006 · Cited by 778
Connective tissue growth factor: a mediator of TGF-β action on fibroblasts
Grotendorst, G. R. (1997) · Cytokine & Growth Factor Reviews · doi:10.1016/s1359-6101(97)00010-5 · Cited by 761
Bleomycin and IL-1β–mediated pulmonary fibrosis is IL-17A dependent
Wilson, M. S., Madala, S. K., Ramalingam, T. R., Gochuico, B. R., Rosas, I. O., Cheever, A. W., & Wynn, T. A. (2010) · Journal of Experimental Medicine · doi:10.1084/jem.20092121 · Cited by 730
Silencing of TGF-β signalling by the pseudoreceptor BAMBI
Onichtchouk, D., Chen, Y.-G., Dosch, R., Gawantka, V., Delius, H., Massague´, J., & Niehrs, C. (1999) · Nature · doi:10.1038/46794 · Cited by 726
Role of cytokines in inflammatory bowel disease
Sanchez-Muñoz, F., Dominguez-Lopez, A., & Yamamoto-Furusho, J. K. (2008) · World Journal of Gastroenterology · doi:10.3748/wjg.14.4280 · Cited by 699
Nox enzymes, ROS, and chronic disease: An example of antagonistic pleiotropy
Lambeth, J. D. (2007) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2007.03.027 · Cited by 679
Verrecchia, F., & Mauviel, A. (2002) · Journal of Investigative Dermatology · doi:10.1046/j.1523-1747.2002.01641.x · Cited by 666
Verrecchia, F., Chu, M.-L., & Mauviel, A. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m100754200 · Cited by 664
Cosnes, J., Nion-Larmurier, I., Beaugerie, L., Afchain, P., Tiret, E., & Gendre, J.-P. (2005) · Gut · doi:10.1136/gut.2004.045294 · Cited by 657
Genome-wide association identifies multiple ulcerative colitis susceptibility loci
The NIDDK IBD Genetics Consortium, McGovern, D. P. B., Gardet, A., Törkvist, L., Goyette, P., Essers, J., Taylor, K. D., Neale, B. M., Ong, R. T. H., Lagacé, C., et al. (2010) · Nature Genetics · doi:10.1038/ng.549 · Cited by 654
Suppressors of cytokine signalling (SOCS) in the immune system
Alexander, W. S. (2002) · Nature Reviews Immunology · doi:10.1038/nri818 · Cited by 645
Insulin-like growth factor 1 (IGF-1): a growth hormone
Laron, Z. (2001) · Molecular Pathology · doi:10.1136/mp.54.5.311 · Cited by 608
Chiaramonte, M. G., Donaldson, D. D., Cheever, A. W., & Wynn, T. A. (1999) · Journal of Clinical Investigation · doi:10.1172/jci7325 · Cited by 603
Franchimont, D., Vermeire, S., El Housni, H., Pierik, M., Van Steen, K., Gustot, T., Quertinmont, E., Abramowicz, M., Van Gossum, A., Devière, J., et al. (2004) · Gut · doi:10.1136/gut.2003.030205 · Cited by 597
Expanding the effector CD4 T-cell repertoire: the Th17 lineage
Harrington, L. E., Mangan, P. R., & Weaver, C. T. (2006) · Current Opinion in Immunology · doi:10.1016/j.coi.2006.03.017 · Cited by 590
Apte, M. V., Haber, P. S., Darby, S. J., Rodgers, S. C., McCaughan, G. W., Korsten, M. A., Pirola, R. C., & Wilson, J. S. (1999) · Gut · doi:10.1136/gut.44.4.534 · Cited by 579
Minireview: Overview of the Renin-Angiotensin System—An Endocrine and Paracrine System
Lavoie, J. L., & Sigmund, C. D. (2003) · Endocrinology · doi:10.1210/en.2003-0150 · Cited by 576
Myofibroblasts. II. Intestinal subepithelial myofibroblasts
Powell, D. W., Mifflin, R. C., Valentich, J. D., Crowe, S. E., Saada, J. I., & West, A. B. (1999) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.1999.277.2.c183 · Cited by 566
Xu, H. E., Lambert, M. H., Montana, V. G., Plunket, K. D., Moore, L. B., Collins, J. L., Oplinger, J. A., Kliewer, S. A., Gampe, R. T., McKee, D. D., et al. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.241410198 · Cited by 538
Land, S. C., & Tee, A. R. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m611782200 · Cited by 507
Matrix Metalloproteinases in Lung: Multiple, Multifarious, and Multifaceted
Greenlee, K. J., Werb, Z., & Kheradmand, F. (2007) · Physiological Reviews · doi:10.1152/physrev.00022.2006 · Cited by 474
Emerging insights into Transforming growth factor Smad signal in hepatic fibrogenesis
Inagaki, Y., & Okazaki, I. (2007) · Gut · doi:10.1136/gut.2005.088690 · Cited by 464
Mutations in NOD2 are associated with fibrostenosing disease in patients with Crohn's disease
Abreu, M. T., Taylor, K. D., Lin, Y.-C., Hang, T., Gaiennie, J., Landers, C. J., Vasiliauskas, E. A., Kam, L. Y., Rojany, M., Papadakis, K. A., et al. (2002) · Gastroenterology · doi:10.1053/gast.2002.35393 · Cited by 428
D'Haens, G. R., Panaccione, R., Higgins, P. D. R., Vermeire, S., Gassull, M., Chowers, Y., Hanauer, S. B., Herfarth, H., Hommes, D. W., Kamm, M., et al. (2011) · American Journal of Gastroenterology · doi:10.1038/ajg.2010.392 · Cited by 409
Targeting mammalian target of rapamycin (mTOR) for health and diseases
Tsang, C. K., Qi, H., Liu, L. F., & Zheng, X. F. S. (2007) · Drug Discovery Today · doi:10.1016/j.drudis.2006.12.008 · Cited by 406
YOSHIJI, H., KURIYAMA, S., YOSHII, J., IKENAKA, Y., NOGUCHI, R., NAKATANI, T., TSUJINOUE, H., & FUKUI, H. (2001) · Hepatology · doi:10.1053/jhep.20001.28231 · Cited by 397
von Lampe, B., Barthel, B., Coupland, S. E., Riecken, E.-O., & Rosewicz, S. (2000) · Gut · doi:10.1136/gut.47.1.63 · Cited by 386
The CXC chemokines, IL-8 and IP-10, regulate angiogenic activity in idiopathic pulmonary fibrosis
Keane, M. P., Arenberg, D. A., Lynch, J. P., Whyte, R. I., Iannettoni, M. D., Burdick, M. D., Wilke, C. A., Morris, S. B., Glass, M. C., DiGiovine, B., et al. (1997) · The Journal of Immunology · doi:10.4049/jimmunol.159.3.1437 · Cited by 382
Babyatsky, M., Rossiter, G., & Podolsky, D. (1996) · Gastroenterology · doi:10.1053/gast.1996.v110.pm8613031 · Cited by 381
Humar, R., Kiefer, F. N., Berns, H., Resink, T. J., & Battegay, E. J. (2002) · The FASEB Journal · doi:10.1096/fj.01-0658com · Cited by 381
Mi, S., Li, Z., Yang, H.-Z., Liu, H., Wang, J.-P., Ma, Y.-G., Wang, X.-X., Liu, H.-Z., Sun, W., & Hu, Z.-W. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1004081 · Cited by 370
Powell, D. W., Mifflin, R. C., Valentich, J. D., Crowe, S. E., Saada, J. I., & Ab, W. (1999) · Cited by 358
Angiotensin II: a key factor in the inflammatory and fibrotic response in kidney diseases
Ruiz-Ortega, M., Rupérez, M., Esteban, V., Rodríguez-Vita, J., Sánchez-López, E., Carvajal, G., & Egido, J. (2006) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfi265 · Cited by 356
The IL-21 receptor augments Th2 effector function and alternative macrophage activation
Pesce, J. (2006) · Journal of Clinical Investigation · doi:10.1172/jci27727 · Cited by 346
Intestinal fibrosis in IBD—a dynamic, multifactorial process
Rieder, F., & Fiocchi, C. (2009) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2009.31 · Cited by 343
Gene regulation of connective tissue growth factor: new targets for antifibrotic therapy?
Blom, I. E., Goldschmeding, R., & Leask, A. (2002) · Matrix Biology · doi:10.1016/s0945-053x(02)00055-0 · Cited by 338
Baldeviano, G. C., Barin, J. G., Talor, M. V., Srinivasan, S., Bedja, D., Zheng, D., Gabrielson, K., Iwakura, Y., Rose, N. R., & Cihakova, D. (2010) · Circulation Research · doi:10.1161/circresaha.109.213157 · Cited by 334
A major role for matrix metalloproteinases in T cell injury in the gut
Pender, S. L., Tickle, S. P., Docherty, A. J., Howie, D., Wathen, N. C., & MacDonald, T. T. (1997) · The Journal of Immunology · doi:10.4049/jimmunol.158.4.1582 · Cited by 326
Umar, S. (2010) · Current Gastroenterology Reports · doi:10.1007/s11894-010-0130-3 · Cited by 323
Inflammation-Induced Endothelial-to-Mesenchymal Transition
Rieder, F., Kessler, S. P., West, G. A., Bhilocha, S., de la Motte, C., Sadler, T. M., Gopalan, B., Stylianou, E., & Fiocchi, C. (2011) · The American Journal of Pathology · doi:10.1016/j.ajpath.2011.07.042 · Cited by 322
Biological origin of free radicals, and mechanisms of antioxidant protection
Gutteridge, J. M. C. (1994) · Chemico-Biological Interactions · doi:10.1016/0009-2797(94)90033-7 · Cited by 318
Antiangiogenic Potential of the Mammalian Target of Rapamycin Inhibitor Temsirolimus
Del Bufalo, D., Ciuffreda, L., Trisciuoglio, D., Desideri, M., Cognetti, F., Zupi, G., & Milella, M. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-2825 · Cited by 317
Wound healing and fibrosis in intestinal disease
Rieder, F., Brenmoehl, J., Leeb, S., Schölmerich, J., & Rogler, G. (2007) · Gut · doi:10.1136/gut.2006.090456 · Cited by 305
Differential Dependence of Hypoxia-inducible Factors 1α and 2α on mTORC1 and mTORC2
Toschi, A., Lee, E., Gadir, N., Ohh, M., & Foster, D. A. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.c800170200 · Cited by 301
Flier, S. N., Tanjore, H., Kokkotou, E. G., Sugimoto, H., Zeisberg, M., & Kalluri, R. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.102012 · Cited by 282
Interleukin-1 participates in the progression from liver injury to fibrosis
Gieling, R. G., Wallace, K., & Han, Y.-P. (2009) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.90564.2008 · Cited by 281
The Role of the Mammalian Target Of Rapamycin (mTOR) in Renal Disease
Lieberthal, W., & Levine, J. S. (2009) · Journal of the American Society of Nephrology · doi:10.1681/asn.2008111186 · Cited by 280
Fibrogenesis in Crohn's Disease
Burke, J. P., Mulsow, J. J., O'Keane, C., Docherty, N. G., Watson, R. W. G., & O'Connell, P. R. (2007) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2006.01010.x · Cited by 279
The role of circulating fibrocytes in fibrosis
Quan, T. E., Cowper, S. E., & Bucala, R. (2006) · Current Rheumatology Reports · doi:10.1007/s11926-006-0055-x · Cited by 263
Crystal Structure of the Ligand Binding Domain of the Human Nuclear Receptor PPARγ
Uppenberg, J., Svensson, C., Jaki, M., Bertilsson, G., Jendeberg, L., & Berkenstam, A. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.47.31108 · Cited by 260
TGF-β and Smad3 Signaling Link Inflammation to Chronic Fibrogenesis
Bonniaud, P., Margetts, P. J., Ask, K., Flanders, K., Gauldie, J., & Kolb, M. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.175.8.5390 · Cited by 252
Increased Immune Reactivity Predicts Aggressive Complicating Crohn's Disease in Children
Dubinsky, M. C., Kugathasan, S., Mei, L., Picornell, Y., Nebel, J., Wrobel, I., Quiros, A., Silber, G., Wahbeh, G., Katzir, L., et al. (2008) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2008.04.032 · Cited by 245
Intestinal myofibroblasts in innate immune responses of the intestine
Otte, J.-M., Rosenberg, I. M., & Podolsky, D. K. (2003) · Gastroenterology · doi:10.1016/s0016-5085(03)00403-7 · Cited by 242
γδ T cells protect against lung fibrosis via IL-22
Simonian, P. L., Wehrmann, F., Roark, C. L., Born, W. K., O'Brien, R. L., & Fontenot, A. P. (2010) · Journal of Experimental Medicine · doi:10.1084/jem.20100061 · Cited by 242
Theiss, A. L., Simmons, J. G., Jobin, C., & Lund, P. K. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m505291200 · Cited by 233
Wu, M., Melichian, D. S., Chang, E., Warner-Blankenship, M., Ghosh, A. K., & Varga, J. (2009) · The American Journal of Pathology · doi:10.2353/ajpath.2009.080574 · Cited by 233
Peroxisome proliferator-activated receptor gamma (PPARγ) and its ligands: A review
Houseknecht, K. L., Cole, B. M., & Steele, P. J. (2002) · Domestic Animal Endocrinology · doi:10.1016/s0739-7240(01)00117-5 · Cited by 232
Török, H.-P., Glas, J., Tonenchi, L., Mussack, T., & Folwaczny, C. (2004) · Clinical Immunology · doi:10.1016/j.clim.2004.03.002 · Cited by 227
Reactive oxygen species: A double-edged sword in oncogenesis
Pan, J.-S., Hong, M.-Z., & Ren, J.-L. (2009) · World Journal of Gastroenterology · doi:10.3748/wjg.15.1702 · Cited by 225
Lung Inflammation and Fibrosis
WARD, P. A., & HUNNINGHAKE, G. W. (1998) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.157.4.nhlbi-10 · Cited by 222
Vaalamo, M., Karjalainen‐Lindsberg, M., Puolakkainen, P. A., Kere, J., & Saarialho‐Kere, U. (1998) · Europe PMC (PubMed Central) · Cited by 218
Hata, K., Andoh, A., Shimada, M., Fujino, S., Bamba, S., Araki, Y., Okuno, T., Fujiyama, Y., & Bamba, T. (2002) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00494.2001 · Cited by 218
Inazaki, K., Kanamaru, Y., Kojima, Y., Sueyoshi, N., Okumura, K., Kaneko, K., Yamashiro, Y., Ogawa, H., & Nakao, A. (2004) · Kidney International · doi:10.1111/j.1523-1755.2004.00779.x · Cited by 217
A murine model of chronic inflammation-induced intestinal fibrosis down-regulated by antisense NF-κB
Lawrance, I. C., Wu, F., Leite, A. Z. A., Willis, J., West, G. A., Fiocchi, C., & Chakravarti, S. (2003) · Gastroenterology · doi:10.1053/j.gastro.2003.08.027 · Cited by 215
The Role of TNFα in Ulcerative Colitis
Sands, B. E., & Kaplan, G. G. (2007) · The Journal of Clinical Pharmacology · doi:10.1177/0091270007301623 · Cited by 214
Zhu, J., Wu, J., Frizell, E., Liu, S.-L., Bashey, R., Rubin, R., Norton, P., & Zern, M. A. (1999) · Gastroenterology · doi:10.1016/s0016-5085(99)70406-3 · Cited by 212
Roles of activin in tissue repair, fibrosis, and inflammatory disease
WERNER, S., & ALZHEIMER, C. (2006) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2006.01.001 · Cited by 209
Di Sabatino, A., Jackson, C. L., Pickard, K. M., Buckley, M., Rovedatti, L., Leakey, N. A. B., Picariello, L., Cazzola, P., Monteleone, G., Tonelli, F., et al. (2009) · Gut · doi:10.1136/gut.2008.149096 · Cited by 209
PPAR-γ agonist attenuates renal interstitial fibrosis and inflammation through reduction of TGF-β
Kawai, T., Masaki, T., Doi, S., Arakawa, T., Yokoyama, Y., Doi, T., Kohno, N., & Yorioka, N. (2009) · Laboratory Investigation · doi:10.1038/labinvest.2008.104 · Cited by 203
McKaig, B. C., McWilliams, D., Watson, S. A., & Mahida, Y. R. (2003) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)63931-4 · Cited by 203
Systemic and pulmonary oxidative stress in idiopathic pulmonary fibrosis
Rahman, I., Skwarska, E., Henry, M., Davis, M., O’Connor, C. M., FitzGerald, M. X., Greening, A., & MacNee, W. (1999) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(99)00035-0 · Cited by 195
Szebeni, B., Veres, G., Dezsõfi, A., Rusai, K., Vannay, Á., Mraz, M., Majorova, E., & Arató, A. (2007) · Clinical and Experimental Immunology · doi:10.1111/j.1365-2249.2007.03531.x · Cited by 194
Infectious disease, the innate immune response, and fibrosis
Meneghin, A., & Hogaboam, C. M. (2007) · Journal of Clinical Investigation · doi:10.1172/jci30595 · Cited by 194
Wei, J., Ghosh, A. K., Sargent, J. L., Komura, K., Wu, M., Huang, Q.-Q., Jain, M., Whitfield, M. L., Feghali-Bostwick, C., & Varga, J. (2010) · PLoS ONE · doi:10.1371/journal.pone.0013778 · Cited by 193
Experimental colitis is ameliorated by inhibition of nitric oxide synthase activity.
Rachmilewitz, D., Karmeli, F., Okon, E., & Bursztyn, M. (1995) · Gut · doi:10.1136/gut.37.2.247 · Cited by 191
Kulkarni, A. A., Thatcher, T. H., Olsen, K. C., Maggirwar, S. B., Phipps, R. P., & Sime, P. J. (2011) · PLoS ONE · doi:10.1371/journal.pone.0015909 · Cited by 189
Hetzel, M., Bachem, M., Anders, D., Trischler, G., & Faehling, M. (2005) · Lung · doi:10.1007/s00408-004-2534-z · Cited by 186
Manoury, B., Nenan, S., Leclerc, O., Guenon, I., Boichot, E., Planquois, J.-M., Bertrand, C. P., & Lagente, V. (2005) · Respiratory Research · doi:10.1186/1465-9921-6-11 · Cited by 186
TGF-β, Smad3 and the process of progressive fibrosis
Gauldie, J., Bonniaud, P., Sime, P., Ask, K., & Kolb, M. (2007) · Biochemical Society Transactions · doi:10.1042/bst0350661 · Cited by 183
Transforming growth factor-β: multifunctional regulator of differentiation and development
Roberts, A. B., Flanders, K. C., Heine, U. I., Jakowlew, S., Kondaiah, P., Kim, S.-J., & Sporn, M. B. (1990) · Philosophical Transactions of the Royal Society of London. B, Biological Sciences · doi:10.1098/rstb.1990.0050 · Cited by 178
Chiaramonte, M. G., Cheever, A. W., Malley, J. D., Donaldson, D. D., & Wynn, T. A. (2001) · Hepatology · doi:10.1053/jhep.2001.26376 · Cited by 174
Sponheim, J., Pollheimer, J., Olsen, T., Balogh, J., Hammarström, C. L., Loos, T., Kasprzycka, M., Sørensen, D. R., Nilsen, H. R., Küchler, A. M., et al. (2010) · American Journal Of Pathology · doi:10.2353/ajpath.2010.100378 · Cited by 172
Tsukada, S., Westwick, J. K., Ikejima, K., Sato, N., & Rippe, R. A. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m409381200 · Cited by 170
Intestinal myofibroblasts: targets for stem cell therapy
Mifflin, R. C., Pinchuk, I. V., Saada, J. I., & Powell, D. W. (2011) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00474.2010 · Cited by 170
Pathogenic angiogenesis in IBD and experimental colitis: new ideas and therapeutic avenues
Chidlow, J. H., Shukla, D., Grisham, M. B., & Kevil, C. G. (2007) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00107.2007 · Cited by 167
The physiology of a local renin–angiotensin system in the pancreas
Leung, P. S. (2007) · The Journal of Physiology · doi:10.1113/jphysiol.2006.126193 · Cited by 166
Genetic Risk Profiling and Prediction of Disease Course in Crohn's Disease Patients
Henckaerts, L., Steen, K. V., Verstreken, I., Cleynen, I., Franke, A., Schreiber, S., Rutgeerts, P. J., & Vermeire, S. (2009) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2009.05.001 · Cited by 165
In Vivo Characterization of Bone Marrow–Derived Fibroblasts Recruited into Fibrotic Lesions
Ishii, G., Sangai, T., Sugiyama, K., Ito, T., Hasebe, T., Endoh, Y., Magae, J., & Ochiai, A. (2005) · Stem Cells · doi:10.1634/stemcells.2004-0183 · Cited by 163
Intestinal fibrosis in inflammatory bowel disease — Current knowledge and future perspectives
Rieder, F., & Fiocchi, C. (2008) · Journal of Crohn's and Colitis · doi:10.1016/j.crohns.2008.05.009 · Cited by 162
Matrix metalloproteinases in inflammatory bowel disease: Boon or a bane?
Ravi, A., Garg, P., & Sitaraman, S. V. (2007) · Inflammatory Bowel Diseases · doi:10.1002/ibd.20011 · Cited by 162
Svegliati‐Baroni, G., Saccomanno, S., Van Goor, H., Jansen, P., Benedetti, A., & Moshage, H. (2001) · Liver · doi:10.1034/j.1600-0676.2001.210101.x · Cited by 160
Fibrogenesis IV. Fibrosis and inflammatory bowel disease: cellular mediators and animal models
Pucilowska, J. B., Williams, K. L., & Lund, P. K. (2000) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.2000.279.4.g653 · Cited by 159
Meijer, M. J. W., Mieremet-Ooms, M. A. C., van der Zon, A. M., van Duijn, W., van Hogezand, R. A., Sier, C. F. M., Hommes, D. W., Lamers, C. B. H. W., & Verspaget, H. W. (2007) · Digestive and Liver Disease · doi:10.1016/j.dld.2007.05.010 · Cited by 156
Distribution and release of epidermal growth factor in man.
Konturek, J. W., Bielański, W., Konturek, S. J., Bogdał, J., & Oleksy, J. (1989) · Gut · doi:10.1136/gut.30.9.1194 · Cited by 156
Bilirubin Ameliorates Bleomycin-Induced Pulmonary Fibrosis in Rats
WANG, H.-D., Yamaya, M., Okinaga, S., JIA, Y.-X., Kamanaka, M., Takahashi, H., GUO, L.-Y., Ohrui, T., & Sasaki, H. (2002) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.165.3.2003149 · Cited by 153
Toll-like receptors, wound healing, and carcinogenesis
Kluwe, J., Mencin, A. M., & Schwabe, R. F. (2008) · Journal of Molecular Medicine · doi:10.1007/s00109-008-0426-z · Cited by 153
Heuschkel, R. B., MacDonald, T. T., Monteleone, G., Bajaj‐Elliott, M., Walker‐Smith, J., & Pender, S. L. F. (2000) · Gut · doi:10.1136/gut.47.1.57 · Cited by 152
Krieg, T., Abraham, D., & Lafyatis, R. (2007) · Arthritis Research & Therapy · doi:10.1186/ar2188 · Cited by 151
Use of sirolimus (rapamycin) to treat refractory Crohn’s disease
Massey, D. C. O., Bredin, F., & Parkes, M. (2008) · Gut · doi:10.1136/gut.2008.157297 · Cited by 151
Louis, E. J., Ribbens, C., Godon, A., Franchimont, D. P., Groote, D. D., Hardy, N., Boniver, J., Bélaïche, J., & Malaise, M. (2000) · Clinical & Experimental Immunology · doi:10.1046/j.1365-2249.2000.01227.x · Cited by 150
Hypoxia-Induced Endothelial Proliferation Requires Both mTORC1 and mTORC2
Li, W., Petrimpol, M., Molle, K. D., Hall, M. N., Battegay, E., & Humar, R. (2006) · Circulation Research · doi:10.1161/01.res.0000253094.03023.3f · Cited by 150
Gao, Q., Meijer, M. J. W., Kubben, F. J. G. M., Sier, C. F. M., Kruidenier, L., van Duijn, W., van den Berg, M., van Hogezand, R. A., Lamers, C. B. H. W., & Verspaget, H. W. (2005) · Digestive and Liver Disease · doi:10.1016/j.dld.2005.02.011 · Cited by 142
From intestinal stem cells to inflammatory bowel diseases.
Gersemann, M., Stange, E. F., & Wehkamp, J. (2011) · World Journal of Gastroenterology · doi:10.3748/wjg.v17.i27.3198 · Cited by 140
Neef, M., Ledermann, M., Saegesser, H., Schneider, V., & Reichen, J. (2006) · Journal of Hepatology · doi:10.1016/j.jhep.2006.07.030 · Cited by 140
IV. Genetic and animal models of GI motility disorders caused by loss of interstitial cells of Cajal
Sanders, K. M., Ördög, T., & Ward, S. M. (2002) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00362.2001 · Cited by 140
PPARγ agonists prevent TGFβ1/Smad3-signaling in human hepatic stellate cells
Zhao, C., Chen, W., Yang, L., Chen, L., Stimpson, S. A., & Diehl, A. M. (2006) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2006.09.069 · Cited by 139
The Interleukin‐23 / Interleukin‐17 axis in intestinal inflammation
Maloy, K. J. (2008) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.2008.01950.x · Cited by 131
Kurikawa, N., Suga, M., Kuroda, S., Yamada, K., & Ishikawa, H. (2003) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0705339 · Cited by 130
Confirmation of Multiple Crohn's Disease Susceptibility Loci in a Large Dutch–Belgian Cohort
Weersma, R. K., Stokkers, P. C. F., Cleynen, I., Wolfkamp, S. C., Henckaerts, L., Schreiber, S., Dijkstra, G. D. H., Franke, A., Nolte, I. M., Rutgeerts, P. J., et al. (2009) · The American Journal of Gastroenterology · doi:10.1038/ajg.2008.112 · Cited by 130
IGF-I and TGF-β1 have distinct effects on phenotype and proliferation of intestinal fibroblasts
Simmons, J. G., Pucilowska, J. B., Keku, T. O., & Lund, P. K. (2002) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00057.2002 · Cited by 129
Endothelin-1 and endothelin-4 stimulate monocyte production of cytokines
Cunningham, M. E. A., Huribal, M., Bala, R. J., & McMillen, M. A. (1997) · Critical Care Medicine · doi:10.1097/00003246-199706000-00011 · Cited by 128
The intracellular renin–angiotensin system: implications in cardiovascular remodeling
Kumar, R., Singh, V., & Baker, K. M. (2008) · Current Opinion in Nephrology & Hypertension · doi:10.1097/mnh.0b013e3282f521a8 · Cited by 127
Zouki, C., Baron, C., Fournier, A., & Filep, J. G. (1999) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0702593 · Cited by 126
In vivo antioxidant treatment protects against bleomycin‐induced lung damage in rats
Serrano‐Mollar, A., Closa, D., Prats, N., Blesa, S., Martínez‐Losa, M., Cortijo, J., Estrela, J. M., Morcillo, E. J., & Bulbena, O. (2003) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0705138 · Cited by 125
Aoki, Y., Maeno, T., Aoyagi, K., Ueno, M., Aoki, F., Aoki, N., Nakagawa, J., Sando, Y., Shimizu, Y., Suga, T., et al. (2008) · Respiration · doi:10.1159/000168676 · Cited by 125
Lawrance, I. C., Maxwell, L. E., & Doe, W. F. (2001) · Inflammatory Bowel Diseases · doi:10.1097/00054725-200108000-00008 · Cited by 125
Yoshizaki, A., Yanaba, K., Yoshizaki, A., Iwata, Y., Komura, K., Ogawa, F., Takenaka, M., Shimizu, K., Asano, Y., Hasegawa, M., et al. (2010) · Arthritis & Rheumatism · doi:10.1002/art.27498 · Cited by 124
Patsenker, E., Schneider, V., Ledermann, M., Saegesser, H., Dorn, C., Hellerbrand, C., & Stickel, F. (2010) · Journal of Hepatology · doi:10.1016/j.jhep.2010.10.044 · Cited by 123
Noncanonical TGF-β pathways, mTORC1 and Abl, in renal interstitial fibrogenesis
Wang, S., Wilkes, M. C., Leof, E. B., & Hirschberg, R. R. (2009) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00320.2009 · Cited by 123
Critical Role for IL-6 in Hypertrophy and Fibrosis in Chronic Cardiac Allograft Rejection
Diaz, J. A., Booth, A. J., Lu, G., Wood, S. C., Pinsky, D. J., & Bishop, D. K. (2009) · American Journal of Transplantation · doi:10.1111/j.1600-6143.2009.02706.x · Cited by 112
Themes in fibrosis and gastrointestinal inflammation
Fiocchi, C., & Lund, P. K. (2011) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00104.2011 · Cited by 112
Leeb, S. N., Vogl, D., Gunckel, M., Kießling, S., Falk, W., Göke, M. N., Schölmerich, J., Gelbmann, C. M., & Rogler, G. (2003) · Gastroenterology · doi:10.1016/j.gastro.2003.07.004 · Cited by 110
Oxidative and Nitrosative Stress and Fibrogenic Response
Urtasun, R., de la Rosa, L. C., & Nieto, N. (2008) · Clinics in Liver Disease · doi:10.1016/j.cld.2008.07.005 · Cited by 110
Stawowy, P., Margeta, C., Kallisch, H., Seidah, N. G., Chrétien, M., Fleck, E., & Graf, K. (2004) · Cardiovascular Research · doi:10.1016/j.cardiores.2004.03.010 · Cited by 110
Aoudjehane, L., Pissaia, A., Scatton, O., Podevin, P., Massault, P. P., Chouzenoux, S., Soubrane, O., Calmus, Y., & Conti, F. (2008) · Laboratory Investigation · doi:10.1038/labinvest.2008.61 · Cited by 107
Hirasawa, K., Sato, Y., Hosoda, Y., Yamamoto, T., & Hanai, H. (2002) · Journal of Histochemistry & Cytochemistry · doi:10.1177/002215540205000215 · Cited by 107
Rottoli, P., Magi, B., Cianti, R., Bargagli, E., Vagaggini, C., Nikiforakis, N., PALLINI, V., & Bini, L. (2005) · PROTEOMICS · doi:10.1002/pmic.200401206 · Cited by 105
Hoffmann, K. F., McCarty, T. C., Segal, D., Chiaramonte, M. G., Hesse, M., Davis, E. M., Cheever, A. W., Meltzer, P. S., Morse, H. C., & Wynn, T. A. (2001) · The FASEB Journal · doi:10.1096/fj.01-0306fje · Cited by 104
Reinisch, W., Panés, J., Lémann, M., Schreiber, S., Feagan, B. G., Schmidt, S. L., Sturniolo, G. C., Mikhailova, T. L., Alexeeva, O., Sanna, L., et al. (2008) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2008.02024.x · Cited by 102
Sabatino, A. D., Pickard, K., Rampton, D. S., Kruidenier, L., Rovedatti, L., Leakey, N., Corazza, G. R., Monteleone, G., & MacDonald, T. T. (2008) · Gut · doi:10.1136/gut.2007.130922 · Cited by 100
Rapamycin Prevents Transforming Growth Factor-α–Induced Pulmonary Fibrosis
Korfhagen, T. R., Cras, T. D. L., Davidson, C. R., Schmidt, S., Ikegami, M., Whitsett, J. A., & Hardie, W. D. (2009) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2008-0377oc · Cited by 99
mTOR as a potential therapeutic target for treatment of keloids and excessive scars
Ong, C., Khoo, Y. T., Mukhopadhyay, A., Do, D. V., Lim, I. J., Aalami, O., & Phan, T. T. (2007) · Experimental Dermatology · doi:10.1111/j.1600-0625.2007.00550.x · Cited by 99
Increased colonic mucosal angiotensin I and II concentrations in Crohn's colitis
Jaszewski, R., Tolia, V., Ehrinpreis, M. N., Bodzin, J. H., Peleman, R. R., Korlipara, R., & Weinstock, J. V. (1990) · Gastroenterology · doi:10.1016/0016-5085(90)91088-n · Cited by 98
The importance of the intrarenal renin–angiotensin system
Velez, J. C. Q. (2008) · Nature Reviews Nephrology · doi:10.1038/ncpneph1015 · Cited by 98
Meijer, M. J. W., Mieremet-Ooms, M. A. C., van Hogezand, R. A., Cb, L., Hommes, D. W., & Verspaget, H. W. (2007) · World Journal of Gastroenterology · doi:10.3748/wjg.v13.i21.2960 · Cited by 97
Prevention of Fibrosis in Experimental Colitis by Captopril: the Role of tgf-β1
Wengrower, D., Zannineli, G., Pappo, O., Latella, G., Sestieri, M., Villanova, A., Faitelson, Y., Pines, M., & Goldin, E. (2004) · Inflammatory Bowel Diseases · doi:10.1097/00054725-200409000-00007 · Cited by 95
Earp, R. H. S., Calvo, B. F., & Sartor, C. I. (2003) · PubMed · Cited by 93
Brenmoehl, J., Miller, S. N., Hofmann, C., Vogl, D., Falk, W., Schölmerich, J., & Rogler, G. (2009) · World Journal of Gastroenterology · doi:10.3748/wjg.15.1431 · Cited by 93
A novel role of activin in inflammation and repair
Munz, B., Hübner, G., Tretter, Y. P., Alzheimer, C., & Werner, S. (1999) · Journal of Endocrinology · doi:10.1677/joe.0.1610187 · Cited by 92
Kapoor, M., McCann, M. R., Liu, S., Huh, K., Denton, C. P., Abraham, D., & Leask, A. (2009) · Arthritis & Rheumatism · doi:10.1002/art.24761 · Cited by 90
Luckett‐Chastain, L. R., & Gallucci, R. M. (2009) · British Journal of Dermatology · doi:10.1111/j.1365-2133.2009.09215.x · Cited by 88
Targeting Matrix Metalloproteinases in Inflammatory Conditions
Clutterbuck, A. L., Asplin, K. E., Harris, P., Allaway, D., & Mobasheri, A. (2009) · Current Drug Targets · doi:10.2174/138945009789753264 · Cited by 87
Klemm, P. L., Warner, T. D., Hohlfeld, T., et al. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.7.2691 · Cited by 86
Pancreatic stellate cells: New target in the treatment of chronic pancreatitis
Talukdar, R., & Tandon, R. K. (2007) · Journal of Gastroenterology and Hepatology · doi:10.1111/j.1440-1746.2007.05206.x · Cited by 85
Inokuchi, Y., Morohashi, T., Kawana, I., Nagashima, Y., Kihara, M., & Umemura, S. (2005) · Gut · doi:10.1136/gut.2003.036343 · Cited by 84
Katsanos, K. H., Tsatsoulis, A. A., Christodoulou, D. K., Challa, A. S., Katsaraki, A., & Tsianos, E. V. (2001) · Growth Hormone & IGF Research · doi:10.1054/ghir.2001.0248 · Cited by 81
Regulation of Migration of Human Colonic Myofibroblasts
Leeb, S. N., Vogl, D., Falk, W., et al. (2002) · Growth Factors · doi:10.1080/08977190290031941 · Cited by 80
Operative Management of Small Bowel Crohn's Disease
Gardiner, K. R., & Dasari, B. V. M. (2007) · Surgical Clinics of North America · doi:10.1016/j.suc.2007.03.011 · Cited by 80
Meijer, M. J. W., Mieremet-Ooms, M. A. C., van Duijn, W., van der Zon, A. M., Hanemaaijer, R., Verheijen, J. H., van Hogezand, R. A., Lamers, C. B. H. W., & Verspaget, H. W. (2006) · Inflammatory Bowel Diseases · doi:10.1002/ibd.20051 · Cited by 79
Liu, X. (2008) · Cell Motility and the Cytoskeleton · doi:10.1002/cm.20315 · Cited by 75
Poulalhon, N., Farge, D., Roos, N., Tacheau, C., Neuzillet, C., Michel, L., Mauviel, A., & Verrecchia, F. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m606366200 · Cited by 75
Predictors of fibrostenotic Crohnʼs disease
Rieder, F., Lawrance, I. C., Leite, A. Z. D. A., & Sans, M. (2011) · Inflammatory Bowel Diseases · doi:10.1002/ibd.21627 · Cited by 74
Tissue Repair, Contraction and the Myofibroblast
Chaponnier, C., Desmoulière, A., & Gabbiani, G. (2006) · Springer eBooks · doi:10.1007/0-387-33650-8 · Cited by 74
Strup-Perrot, C., Mathé, D., Linard, C., Violot, D., Milliat, F., François, A., Bourhis, J., & Vozenin, M. (2004) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00088.2004 · Cited by 72
Human intestinal epithelial and smooth muscle cells are potent producers of IL‐6
Ng, E. K., Panesar, N. K., Longo, W. E., Shapiro, M. J., Kaminski, D. L., Tolman, K. C., & Mazuski, J. E. (2003) · Mediators of Inflammation · doi:10.1080/0962935031000096917 · Cited by 71
Tan, X., Dagher, H., Hutton, C. A., & Bourke, J. E. (2010) · Respiratory Research · doi:10.1186/1465-9921-11-21 · Cited by 70
Bhogal, R. K., & Bona, C. A. (2008) · International Reviews of Immunology · doi:10.1080/08830180802430974 · Cited by 69
Jobson, T. M., Billington, C. K., & Hall, I. P. (1998) · Journal of Clinical Investigation · doi:10.1172/jci1876 · Cited by 67
Nan, Y., Han, F., Kong, L.-B., Zhao, S., Wang, R., Wu, W., & Yu, J. Q. (2010) · Scandinavian Journal of Gastroenterology · doi:10.3109/00365521.2010.525717 · Cited by 66
Ito, H. (2003) · Current Drug Target -Inflammation & Allergy · doi:10.2174/1568010033484296 · Cited by 65
Cytokines mediating the induction of chronic colitis and colitis-associated fibrosis
Fichtner‐Feigl, S., Strober, W., Geissler, E. K., & Schlitt, H. (2008) · Mucosal Immunology · doi:10.1038/mi.2008.41 · Cited by 65
The IL-4Rα pathway in macrophages and its potential role in silica-induced pulmonary fibrosis
Migliaccio, C. T., Buford, M. C., Jessop, F., & Holian, A. (2007) · Journal of Leukocyte Biology · doi:10.1189/jlb.0807533 · Cited by 65
Genetics of inflammatory bowel disease: clues to pathogenesis
Zhang, H., Massey, D. C. O., Tremelling, M., & Parkes, M. (2008) · British Medical Bulletin · doi:10.1093/bmb/ldn031 · Cited by 63
Hayashida, T., & Schnaper, H. W. (2004) · Journal of the American Society of Nephrology · doi:10.1097/01.asn.0000133198.74973.60 · Cited by 63
Latella, G., Vetuschi, A., Sferra, R., Zanninelli, G., D’Angelo, A., Catitti, V., Caprilli, R., Flanders, K. C., & Gaudio, E. (2009) · European Journal of Clinical Investigation · doi:10.1111/j.1365-2362.2008.02076.x · Cited by 62
Rosiglitazone prevents murine hepatic fibrosis induced by Schistosoma japonicum
Chen, H., He, Y., Liu, W., & Zhang, J. (2008) · World Journal of Gastroenterology · doi:10.3748/wjg.14.2905 · Cited by 61
Sofroniadou, S., & Goldsmith, D. (2011) · Drug Safety · doi:10.2165/11585040-000000000-00000 · Cited by 60
Tumor Necrosis Factor Blockade for Treatment of Inflammatory Bowel Disease: Efficacy and Safety
Ngo, B., Farrell, C., Barr, M., Wolov, K., Bailey, R. J., Mullin, J. M., & Thornton, J. J. (2010) · Current Molecular Pharmacology · doi:10.2174/1874467211003030145 · Cited by 60
Geissler, E. K., & Schlitt, H. J. (2010) · Kidney International · doi:10.1038/ki.2010.324 · Cited by 59
Ajlouni, Y., Iser, J. H., & Gibson, P. R. (2006) · Journal of Gastroenterology and Hepatology · doi:10.1111/j.1440-1746.2006.04764.x · Cited by 59
Cited by
Immunopathogenesis of IBD: current state of the art
de Souza, H. S. P., & Fiocchi, C. (2016) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2015.186 · Cited by 1,551
Crohn's disease complicated by strictures: a systematic review
Rieder, F., Zimmermann, E. M., Remzi, F. H., & Sandborn, W. J. (2013) · Gut · doi:10.1136/gutjnl-2012-304353 · Cited by 513
Galectin-3: One Molecule for an Alphabet of Diseases, from A to Z
Sciacchitano, S., Lavra, L., Morgante, A., Ulivieri, A., Magi, F., De Francesco, G., Bellotti, C., Salehi, L., & Ricci, A. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19020379 · Cited by 377
IDIOPATHIC EPIRETINAL MEMBRANE
Bu, S.-C., Kuijer, R., Li, X.-R., Hooymans, J. M. M., & Los, L. I. (2014) · Retina · doi:10.1097/iae.0000000000000349 · Cited by 273
Functions of Galectin-3 and Its Role in Fibrotic Diseases
Li, L.-C., Li, J., & Gao, J. (2014) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.114.218370 · Cited by 261
Metadata
- Authors
- Speca, S.
- Venue
- World Journal of Gastroenterology
- Publisher
- Baishideng Publishing Group Inc.
- Published
- 2012
- Volume
- 18
- Issue
- 28
- Pages
- 3635
- ISSN
- 1007-9327 (ISSN-L)
- OpenAlex
- W2113690494
- Cited by
- 272
- References
- 234
- FWCI
- 8.15
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.